bispecific antibody therapy support | care team members and resources
Published 3 months ago • 3 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
3:21
what is the role of a care partner in bispecific antibody therapy?
-
1:52
how is bispecific antibody therapy changing myeloma care?
-
2:58
how can bispecific antibody therapy care partners be proactive?
-
1:33
how has bispecific antibody therapy impacted myeloma care?
-
1:13
what is the role of bispecific antibody therapy in the future of myeloma care?
-
2:30
how is bispecific antibody therapy administered?
-
1:55
bispecific antibodies for myeloma | patient eligibility requirements
-
25:45
care partners | what should you know about the bispecific antibody treatment for myeloma?
-
9:34
targeting of myeloma disease progression and bispecific antibody advantages
-
5:58
what myeloma patients need to know about bispecific antibodies
-
3:00
how are bispecific antibodies being used in diffuse large b-cell lymphoma treatment?
-
5:13
relapsed/refractory follicular lymphoma treatments and bispecific antibodies
-
2:29
what’s the news on follicular lymphoma and bispecific antibodies?
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
45:42
what you need to know about bispecific antibody immunotherapy
-
4:26
what are bispecific antibodies?
-
4:01
what are the differences between car t-cell therapy and bispecific antibodies?
-
3:25
what should myeloma patients know about bispecific antibodies?
-
2:06
patient role in bispecific antibody treatment - blood cancer onctalk 2023